Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2
Abstract Novel coronavirus 19 (COVID‐19) is the latest and most intense epidemic, which is caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). In addition to causing respiratory symptoms, SARS‐CoV‐2 can have severe effects on the nervous system. Clinically, COVID‐19 patients...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2021-12-01
|
| Series: | Ibrain |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ibra.12008 |
| _version_ | 1811328370136317952 |
|---|---|
| author | Mei‐Fang Xiao Zhi‐Jian You Chang Zeng Ze‐Bing Huang Liang Dong |
| author_facet | Mei‐Fang Xiao Zhi‐Jian You Chang Zeng Ze‐Bing Huang Liang Dong |
| author_sort | Mei‐Fang Xiao |
| collection | DOAJ |
| description | Abstract Novel coronavirus 19 (COVID‐19) is the latest and most intense epidemic, which is caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). In addition to causing respiratory symptoms, SARS‐CoV‐2 can have severe effects on the nervous system. Clinically, COVID‐19 patients have been reported ranging from mild hypogeusia and hyposmia to severe neurological disorders, such as encephalopathy, encephalitis, strokes, and seizures syndrome. However, the pathological mechanisms of this SARS‐CoV‐2 neuro aggressiveness remain unclear, so it is of great significance to explore the neurological effects of SARS‐CoV‐2 infection. To facilitate clinicians to timely recognize the manifestations of COVID‐19 patients with neurological injury and timely treatment, the author hereby reviews the latest research progress in the possible pathways, clinical manifestations, and pathogenesis of COVID‐19 patients with nerve injury. |
| first_indexed | 2024-04-13T15:24:57Z |
| format | Article |
| id | doaj.art-ddf84407266447b787c6ae807c283749 |
| institution | Directory Open Access Journal |
| issn | 2769-2795 |
| language | English |
| last_indexed | 2024-04-13T15:24:57Z |
| publishDate | 2021-12-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Ibrain |
| spelling | doaj.art-ddf84407266447b787c6ae807c2837492022-12-22T02:41:33ZengWiley-VCHIbrain2769-27952021-12-017435136110.1002/ibra.12008Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2Mei‐Fang Xiao0Zhi‐Jian You1Chang Zeng2Ze‐Bing Huang3Liang Dong4Health Management Center, Xiangya Hospital Central South University Changsha Hunan ChinaDepartment of Anesthesiology Liuzhou People's Hospital Affiliated to Guangxi Medical University Liuzhou Guangxi ChinaHealth Management Center, Xiangya Hospital Central South University Changsha Hunan ChinaDepartment of Infectious Diseases, Xiangya Hospital Central South University Changsha Hunan ChinaDepartment of Anesthesiology Liuzhou People's Hospital Affiliated to Guangxi Medical University Liuzhou Guangxi ChinaAbstract Novel coronavirus 19 (COVID‐19) is the latest and most intense epidemic, which is caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). In addition to causing respiratory symptoms, SARS‐CoV‐2 can have severe effects on the nervous system. Clinically, COVID‐19 patients have been reported ranging from mild hypogeusia and hyposmia to severe neurological disorders, such as encephalopathy, encephalitis, strokes, and seizures syndrome. However, the pathological mechanisms of this SARS‐CoV‐2 neuro aggressiveness remain unclear, so it is of great significance to explore the neurological effects of SARS‐CoV‐2 infection. To facilitate clinicians to timely recognize the manifestations of COVID‐19 patients with neurological injury and timely treatment, the author hereby reviews the latest research progress in the possible pathways, clinical manifestations, and pathogenesis of COVID‐19 patients with nerve injury.https://doi.org/10.1002/ibra.12008ACE‐2 receptorsCOVID‐19neurological symptomspathological mechanisms |
| spellingShingle | Mei‐Fang Xiao Zhi‐Jian You Chang Zeng Ze‐Bing Huang Liang Dong Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 Ibrain ACE‐2 receptors COVID‐19 neurological symptoms pathological mechanisms |
| title | Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 |
| title_full | Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 |
| title_fullStr | Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 |
| title_full_unstemmed | Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 |
| title_short | Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 |
| title_sort | update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus 2 |
| topic | ACE‐2 receptors COVID‐19 neurological symptoms pathological mechanisms |
| url | https://doi.org/10.1002/ibra.12008 |
| work_keys_str_mv | AT meifangxiao updateonneurologicalsymptomsinpatientsinfectedwithsevereacuterespiratorysyndromecoronavirus2 AT zhijianyou updateonneurologicalsymptomsinpatientsinfectedwithsevereacuterespiratorysyndromecoronavirus2 AT changzeng updateonneurologicalsymptomsinpatientsinfectedwithsevereacuterespiratorysyndromecoronavirus2 AT zebinghuang updateonneurologicalsymptomsinpatientsinfectedwithsevereacuterespiratorysyndromecoronavirus2 AT liangdong updateonneurologicalsymptomsinpatientsinfectedwithsevereacuterespiratorysyndromecoronavirus2 |